期刊文献+

采用HPLC方法测定氟伐他汀钠分散片的含量 被引量:6

Determination of fluvastatin sodium dispersible tablets by HPLC
下载PDF
导出
摘要 目的:建立HPLC测定氟伐他汀钠分散片中氟伐他汀钠含量的方法.方法:色谱柱:THERMO C18(4.6 mm×250 mm,5μm),检测波长:305 nm,流量:1.2 mL.min-1,进样量:20μL,流动相:0.01 mol.L-1磷酸氢二钠(pH=3.0)-乙腈为40∶60.结果:氟伐他汀钠在0~100μg.mL-1范围内呈现良好的线性关系,Y=3.453 11×104X-5 107.918 4((R=0.999 9),含量测定的RSD(相对标准偏差)为1.008%.平均回收率100.34%,RSD=0.41%.结论:本方法简单,快速、准确、重现性好,可以用作氟伐他汀钠分散片的含量测定. Objective:To establish HPLC method for determining the content of fluvastatin sodium dispersible tablets.Method:Thermo C18 column was used and the mobile phase was 0.01mol·L-1 disodium hydrogen phosphate and acetonitrile(40∶60),flow rate was 1.2mL·min-1,wavelength was UV at 305nm and the sample volume was 20μL.Results:The fluvastatin sodium concentration had good liner relationship from 0~100μg·mL-1,Y=3.45311×104X-5107.9184(R=0.9999).The relative standard deviation of the determination is 1.008%.The average recovery was 100.34%,RSD=0.41%.Conclusion:The method was simple,fast,accurate,and precise,could be use to determine the content of fluvastatin sodium dispersible tablets.
出处 《吉林化工学院学报》 CAS 2011年第1期23-25,共3页 Journal of Jilin Institute of Chemical Technology
关键词 氟伐他汀钠 HPLC 含量测定 fluvastatin sodium HPLC determination of content
  • 相关文献

参考文献3

二级参考文献21

  • 1江启蓉,叶云,戚明双.氟伐他汀的非降脂作用及用途[J].中国药物与临床,2004,4(10):783-784. 被引量:2
  • 2何敏,王向军,姚彤炜.血浆中氟伐他汀测定方法的研究及其应用[J].中国药学杂志,2006,41(2):132-134. 被引量:2
  • 3关爱阁,翟所迪,刘芳.他汀类药物与辅酶Q_(10)联合应用的机制分析[J].中国药房,2006,17(13):1021-1023. 被引量:10
  • 4[1]William R,Garnett,PharmD.A review of current clinical findings with fluvastatin.Am J Cardiol,1996,78(6):20-25.
  • 5[2]Charity D Scripture,John A Pieper.Clinical pharmacokinetics of fluvastatin.Clin pharmacokinet,2001,40(4):263-281.
  • 6[3]Volker Fischer,Laurie Johanson,Francis Heitz,et al.The 3 -hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin:effect on human cytochrome p-450 and implications for metabolic drug interactions.Drug Metab Dispos,1998,27(3):410-415.
  • 7[5]Baetta R.Proapoptotic effect of atorvastatin on stimulated smooth muscle cells.Pharmacol Res,1997,36:2115-2121.
  • 8[6]Corsini A.Inhibitor of proliferation of arterial smooth muscle cells by fluvastatin.Lancet,1996,348:1584.
  • 9[7]Soma MR.HMG-COA reductase inhibitors.In vivo effects on carotid intimal thickening in normal cholestereolemic rabbits.Arterioscler Thromb,1993,13:517-557.
  • 10[8]Foley DP.Prevention of restenosis after coronary balloon angioplasty:rationale and design of the Fluvastatin Angioplasty Restenosis(FLARE)trial.Am J Cardiol,1994,73:50-61.

共引文献17

同被引文献29

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部